MAM
HAE icon

Meeder Asset Management’s Haemonetics HAE Stock Holding History

Meeder Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-261
Closed -$19.5K – 859
2025
Q2 		$19.5K Buy
+261
New +$17.3K ﹤0.01% 524
2023
Q2 		– Sell
-155
Closed -$12.8K – 545
2023
Q1 		$12.8K Sell
155
-187
-55% -$15.1K ﹤0.01% 491
2022
Q4 		$26.9K Buy
342
+135
+65% +$10.9K ﹤0.01% 585
2022
Q3 		$15K Buy
207
+18
+10% +$1.29K ﹤0.01% 1191
2022
Q2 		$12K Buy
189
+58
+44% +$3.43K ﹤0.01% 1309
2022
Q1 		$8K Buy
131
+94
+254% +$5.11K ﹤0.01% 1632
2021
Q4 		$2K Buy
37
+15
+68% +$914 ﹤0.01% 976
2021
Q3 		$2K Sell
22
-23
-51% -$1.45K ﹤0.01% 2182
2021
Q2 		$3K Sell
45
-253
-85% -$17.9K ﹤0.01% 2100
2021
Q1 		$33K Buy
298
+294
+7,350% +$36.4K ﹤0.01% 1241
2020
Q4 		$0 Hold
4
– – ﹤0.01% 2016
2020
Q3 		$0 Buy
4
+2
+100% +$175 ﹤0.01% 2251
2020
Q2 		$0 Sell
2
-979
-100% -$98.9K ﹤0.01% 2214
2020
Q1 		$98K Buy
981
+280
+40% +$30.4K 0.01% 723
2019
Q4 		$81K Sell
701
-3,366
-83% -$407K ﹤0.01% 854
2019
Q3 		$512K Buy
+4,067
New +$516K 0.03% 400
2019
Q2 		– Sell
-144
Closed -$13K – 2073
2019
Q1 		$13K Sell
144
-345
-71% -$31.4K ﹤0.01% 1165
2018
Q4 		$50K Buy
489
+84
+21% +$8.82K ﹤0.01% 814
2018
Q3 		$46K Sell
405
-11,692
-97% -$1.21M ﹤0.01% 801
2018
Q2 		$1.08M Buy
12,097
+9,992
+475% +$844K 0.09% 194
2018
Q1 		$154K Buy
2,105
+220
+12% +$15.1K 0.01% 482
2017
Q4 		$110K Buy
1,885
+1,821
+2,845% +$95.9K 0.01% 549
2017
Q3 		$3K Buy
+64
New +$2.66K ﹤0.01% 1373

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Meeder Asset Management's HAE Position: Q3 2025 in Review

Meeder Asset Management sold out of Haemonetics (HAE) in Q3 2025, closing a stake of 261 shares — an estimated $19.5K sold.

Meeder Asset Management first reported a position in HAE in Q3 2017 and held it in 23 quarters. The position peaked at $1.08M in Q2 2018. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

  • Meeder Asset Management reported no remaining Haemonetics position as of Q3 2025 after selling out during the quarter.
  • Meeder Asset Management sold 261 Haemonetics shares in Q3 2025, an estimated $19.5K.
  • Meeder Asset Management first reported a position in Haemonetics in Q3 2017 and held it in 23 quarters.
  • Meeder Asset Management's Haemonetics position peaked at $1.08M in Q2 2018.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on Meeder Asset Management's 13F filing for Q3 2025, filed 24 Oct 2025.